Binding of N-acetylbenzidine and N,N′-diacetylbenzidine to hepatic DNA of rat and hamster in vivo and in vitro

Publisher Website
Google Scholar
Abstract
Benzidine, a potent hepatocarcinogen in rodents, is readily metabolised to acetylated derivatives. In this study, the covalent binding of [3H-acetyl]N-acetylbenzidine and [3H-acetyl]N,N′-diacetylbenzidine to liver DNA in rats and hamsters was investigated. Binding to liver DNA of rats at 1 or 7 days after i.p. injection of N-acetylbenzidine was 2-fold higher than that observed in the liver DNA of hamsters which had been similarly treated. Analysis of enzymically hydrolysed DNA from both species indicated the presence of a single adduct which co-eluted with N-(deoxyguanosin-8-yl)-N′ -acetylbenzidine. In vitro treatment of rat or hamster liver slices with N-acetylbenzidine also resulted in covalent binding to hepatic DNA and the identical DNA adduct was detected at levels comparable to that observed in vivo. When N,N′-diacetylbenzidine was injected i.p. into rats, a comparatively low level of binding to liver DNA was observed. Following enzymic hydrolysis, the major DNA adduct detected by h.p.l.c. analysis was again N-(deoxyguanosin-8-yl)-N′-acetylbenzidine accompanied by a small amount of N-(deoxyguanosin-8-yl)-N,N′-diacetylbenzidine. In vitro incubation of N,N′-diacetylbenzidine with rat liver slices resulted in DNA binding levels similar to that observed with N-acetylbenzidine. In contrast to what was found in vivo, N-(deoxyguanosin-8-yl)-N,N′-diacetylbenzidine was the major adduct detected in DNA from rat liver slices. These data suggest that both N-hydroxy-N′-acetylbenzidine and N-hydroxy-N,N′-diacetylbenzidine are proximate carcinogenic species of benzidine, with N-hydroxy-N'-acetylbenzidine the more important. The low level of N-(deoxyguanosin-8-yl)N,N′-diacetylbenzidine observed in vivo may be due to its rapid repair. Alternatively, N-sulphonyloxy-N,N′-diacetylbenzidine, which would produce this adduct on reaction with DNA, may be efficiently detoxified in vivo.